Whole Genome Expression Array Profiling Highlights Differences in Mucosal Defense Genes in Barrett's Esophagus and Esophageal Adenocarcinoma
2011

Gene Expression Differences in Barrett's Esophagus and Esophageal Adenocarcinoma

Sample size: 54 publication 10 minutes Evidence: high

Author Information

Author(s): Derek J. Nancarrow, Andrew D. Clouston, B. Mark Smithers, David C. Gotley, Paul A. Drew, David I. Watson, Sonika Tyagi, Nicholas K. Hayward, David C. Whiteman

Primary Institution: Queensland Institute of Medical Research, Herston, Queensland, Australia

Hypothesis

Applying a standardized approach to analyze data from multiple studies will produce a robust core gene list that differentiates between squamous, Barrett's esophagus (BE), and esophageal adenocarcinoma (EAC) tissue types.

Conclusion

The study identifies key gene expression differences that suggest Barrett's esophagus serves as a protective tissue against gastro-esophageal reflux, while esophageal adenocarcinoma shows reduced mucosal defenses.

Supporting Evidence

  • Barrett's esophagus is associated with enhanced mucosal defenses against gastro-esophageal reflux.
  • Esophageal adenocarcinoma shows reduced expression of genes related to mucosal defenses.
  • Gene expression profiling can help distinguish between squamous epithelium, Barrett's esophagus, and esophageal adenocarcinoma.

Takeaway

This study looked at tissue samples from people with Barrett's esophagus and esophageal cancer to find out how their genes are different, helping us understand how these conditions develop.

Methodology

Comparative genome-wide expression profiling using Illumina whole-genome Beadarrays on RNA extracted from esophageal biopsy tissues.

Potential Biases

Potential misclassification of tissue types due to contamination in biopsy samples.

Limitations

The study design may be weakened by the need to analyze samples from each study independently due to technical and experimental differences.

Participant Demographics

Participants aged 18 to 80 years, with a diagnosis of Barrett's esophagus or esophageal adenocarcinoma.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1371/journal.pone.0022513

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication